Chronic inhibition of HMGB1 by glycyrrhizin, a natural anti-inflammatory factor that binds HMGB1 directly, also protects against the development of PAH in MCT-treated rats [11]. The gene discussed is HMGB1; the disease is pulmonary arterial hypertension.